Live Breaking News & Updates on Anant narayan bhatt

Stay informed with the latest breaking news from Anant narayan bhatt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Anant narayan bhatt and stay connected to the pulse of your community

DRDO's anti-Covid drug 2-DG found effective against all variants: Study

DRDO's anti-Covid drug 2-DG found effective against all variants: Study
indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.

Lee-pharma , Yogesh-rai , Dhiviya-vedagiri , Abhishek-kumar , Anant-narayan-bhatt , Development-organisation , Defence-research , All-you-need-to-know-about , லீ-பார்மா , யோகேஷ்-ராய் , அபிஷேக்-குமார் , வளர்ச்சி-ஆர்கநைஸேஶந்

2-DG effective against all Covid variants, says study

2-DG effective against all Covid variants, says study
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

Delhi , India , Hyderabad , Andhra-pradesh , Ghaziabad , Uttar-pradesh , Sudhir-chandna , Dhiviya-vedagiri , C-vijaya-kumar , Krishnanh-harshan , Abhishek-kumar , Yogesh-rai

Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients today

Union Defence Minister, Rajnath Singh (Photo/ANI)
Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients today
ANI |
Updated: May 17, 2021 04:49 IST
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Rajnath Singh's office tweeted,"Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories."

Hyderabad , Andhra-pradesh , India , Karnataka , New-delhi , Delhi , Tamil-nadu , Uttar-pradesh , Telangana , Rajnath-singh , Narendra-modi , Raksha-mantri-rajnath-singh

Rajnath Singh to release first batch of DRDO's 2DG Covid medicine today

The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Rajnath Singh's office tweeted,"Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories."
The first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation officials to ANI on Friday.

Uttar-pradesh , India , Karnataka , Delhi , Hyderabad , Andhra-pradesh , Telangana , Tamil-nadu , Rajnath-singh , Narendra-modi , Raksha-mantri-rajnath-singh , Anant-narayan-bhatt

Over 10,000 doses of DRDO's anti-COVID-19 drug 2-DG to be available from next week

Source:
Highlights
The first batch of 10,000 doses of the 2-DG drug would be launched early next week, informed DRDO on May 14.
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and reduces oxygen dependence.
New Delhi: The first batch of 10,000 doses of the 2-DG drug for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday (May 14, 2021).
The official informed, "The first batch of 10,000 doses of 2-DG medicine for the treatment of COVID-19 infected patients would be launched early next week and will be given to patients."
"The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt", informed DRDO officials.

Karnataka , India , Hyderabad , Andhra-pradesh , New-delhi , Delhi , Anant-narayan-bhatt , Karnataka-health , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Karnataka-health-ministerk-sudhakar

DRDO to launch 2DG medicine for treating Covid-19 patients next week

The first batch of 10,000 doses of 2DG medicine for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday.
The official informed, "The first batch of 10,000 doses of 2DG medicine for the treatment of COVID-19 infected patients would be launched early next week and will be given to patients."
"The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt", informed DRDO officials.
Yesterday, Karnataka Health Minister Dr K Sudhakar visited DRDO campus.DRDO scientists briefed Minister about the 2-DG drug which could be a game-changer in the COVID-19 battle.

Karnataka , India , Hyderabad , Andhra-pradesh , Anant-narayan-bhatt , Karnataka-health , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Karnataka-health-minister-drk-sudhakar , Oxycare-system , Nuclear-medicine

DRDO to launch 2-DG drug for COVID-19 treatment next week

DRDO to launch 2-DG drug for COVID-19 treatment next week
The first batch of 10,000 doses of 2DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials
BusinessToday.In | May 15, 2021 | Updated 11:53 IST
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence
The first tranche of 10,000 doses of 2-DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials on Friday, May 14.
The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad.

Karnataka , India , Hyderabad , Andhra-pradesh , Anant-narayan-bhatt , Karnataka-health , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Health-minister

First batch of DRDO's anti-COVID-19 drug 2DG to be available from next week

Last Updated:
First Batch Of DRDO's Anti-COVID-19 Drug 2DG To Be Available From Next Week
The first batch of 2DG medicine for treating COVID-19 patients would be launched early next week, Defense Research & Development Organisation (DRDO) said.
Image: ANI/DRDO_Twitter
The first batch of 2DG medicine for treating COVID-19 patients would be launched early next week, Defense Research & Development Organisation (DRDO) said on May 14. Speaking to ANI, DRDO officials said that as many as 10,000 doses of the drug would be administrated across India. Jointly developed by DRDO and Dr Reddy’s Laboratories (DRL), the drug has been found to expedite recovery in coronavirus patients and also reduce their dependency on oxygen. On May 1, the 2-deoxy-D-glucose (2DG) medicine was granted approval for emergency use in India.

Uttar-pradesh , India , Karnataka , Delhi , Hyderabad , Andhra-pradesh , Telangana , Tamil-nadu , Anant-narayan-bhatt , Defense-research-development-organisation , Institute-of-nuclear-medicine , Defense-research

DRDO's 2DG Covid medicine to launch next week: Crucial in recovery of patients

12:59 PM
Though India is currently experiencing a oxygen and vaccine shortage, there is some good news on the horizon. The Defense Research and Development Organization has announced that the first batch of 2-deoxy-D-glucose (2-DG) medicine for the treatment of mild to serious Covid-19 cases will be available next week. “The first batch of 10,000 doses of 2DG medicine for the treatment of COVID-19 infected patients will be launched early next week and given to patients,” the official said.
“The pharma companies are working to increase the production of the medication for potential use. A team of DRDO scientists, led by Dr. Anant Narayan Bhatt, created the drug “officials have said. 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, was created in cooperation with Dr Reddys Laboratories (DRL) in Hyderabad by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organization (DRDO).

Karnataka , India , Hyderabad , Andhra-pradesh , Bharat , Anant-narayan-bhatt , Deepak-sapra , Defense-research , Karnataka-health , Development-organization , Institute-of-nuclear-medicine , Defence-research

Coronavirus Live News Updates: DRDO's 2DG medicine for treating COVID-19 patients to be launched next week

Economic Times | 15 May, 2021 | 11.50PM IST
Covid News Updates: Partial coronavirus curfew in Uttar Pradesh extended till 7 am of May 24
India reports 3,26,098 new Covid cases, 3,890 deaths in the last 24 hours
For 4th consecutive day recoveries (3,53,299) outnumbered new cases
Chhattisgarh extends lockdown till May 31
West Bengal imposes total lockdown till May 30
Curfew extended in Himachal Pradesh till May 26
!
11:50 PM
Centre to increase Telangana's oxygen supply
The Centre has nodded to increase State's Oxygen requirement to an additional 200 tonnes. Supply of Remdesivir injections to be increased to 10,500 from Monday onwards. It has also responded positively on the demand to increase vaccine supply: Chief Minister's Office, Telangana

Anant-narayan-bhatt , Development-organisation , Defence-research , வளர்ச்சி-ஆர்கநைஸேஶந் , பாதுகாப்பு-ஆராய்ச்சி ,